Title: A Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Safety Study of Pulmonary Function in Patients with Reduced Lung Function Treated with BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Focal Upper Limb Spasticity Due to Upper Motor Neuron Syndrome
Protocol Study #: 191622-057
Principal Investigator: Allison Brashear, M.D.
The purpose of this study is to investigate the potential effect of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex (designated as BOTOX®) on breathing function in patients with muscle tightness (spasticity) in one arm and hand after experiencing an acquired brain injury, such as a stroke, and also have decreased breathing function not necessarily related to the acquired brain injury.
There will be a total of 9 study visits over a period of approximately 32 weeks
Entry Criteria
- be at least 18 years of age
- have had a stable breathing condition over the past 4 months
- have experienced an acquired brain injury, such as a stroke, and have spasticity in one arm and hand
Contact: Karen Jackson
336-716-9056
kjackson@wfubmc.edu
Sponsor: Allergan Pharmaceuticals -- Enrolling